Early stopping of clinical trials: Charting the ethical terrain

Kennedy Institute of Ethics Journal

Volumn 21, Issue 1, 2011, Pages 51-78

  Malmqvist, Erik ^a   Juth, Niklas ^a   Lynöe, Niels ^a   Helgesson, Gert ^a  

^a The Swedish Children's Cancer Foundation   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT; DOUBLE BLIND PROCEDURE; ECONOMICS; EQUIPOISE; ETHICS; EVIDENCE BASED MEDICINE; HUMAN; INFORMED CONSENT; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS; RESEARCH SUBJECT; SAFETY; STANDARD; THERAPEUTIC MISCONCEPTION; TIME; TREATMENT OUTCOME;

CLINICAL TRIALS, PHASE III AS TOPIC; CONFLICT (PSYCHOLOGY); DOUBLE-BLIND METHOD; ETHICS, RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; INFORMED CONSENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUBJECTS; SAFETY; THERAPEUTIC EQUIPOISE; THERAPEUTIC MISCONCEPTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 79957846225     PISSN: 10546863     EISSN: 10863249     Source Type: Journal    
DOI: 10.1353/ken.2011.0002     Document Type: Article

References (51)

1. Appelbaum, Paul S.; Roth, Loren; Lidz, Charles W.; et al. 1987. False Hope and Best Data: Consent to Research and the Therapeutic Misconception. Hastings Center Report 17 (2): 20-24.
2. Bassler, Dirk; Montori, Victor M.; Briel, Matthias; et al. 2008. Early Stopping of Randomized Clinical Trials for Overt Efficacy Is Problematic. Journal of Clinical Epidemiology 61: 241-46.
3. Baum, Michael; Houghton, Joan; and Abrams, Keith. 1994. Early Stopping Rules-Clinical Perspectives and Ethical Considerations. Statistics in Medicine 13: 1293-95.
4. Baum, Michael; Budzar, Aman; Cuzick, Jack; et al. 2002. Anastrozole Alone or in Combination with Tamoxifen Versus Tamoxifen Alone for Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer: First Results of the ATAC Randomized Trial. Lancet 359: 2131-39.
5. Beauchamp, Tom L., and Childress, James F. 2008. Principles of Biomedical Ethics. 6th ed. Oxford: Oxford University Press.
6. Bryant, John, and Wolmark, Norman. 2003. Letrozole after Tamoxifen for Breast Cancer-What Is the Price of Success? New England Journal of Medicine 349(19): 1855-57.
7. Buchanan, David R., and Miller, Franklin G. 2005. Principles of Early Stopping of Randomized Trials for Efficacy: A Critique of Equipoise and an Alternative Non-Exploitation Ethical Framework. Kennedy Institute of Ethics Journal 15: 161-78.
8. Buchanan, David R., and Miller, Franklin G. 2006. A Public Health Perspective on Research Ethics. Journal of Medical Ethics 32: 729-33.
9. Cannistra, Stephen A. 2004. The Ethics of Early Stopping Rules: Who Is Protecting Whom? Journal of Clinical Oncology 9: 1542-45.
10. Chwang, Eric. 2008. Against the Inalienable Right to Withdraw from Research. Bioethics 22: 370-78.
11. Coombes, R. Charles; Hall, Emma; Gibson, Lorna J.; et al. 2004. A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Post-Menopausal Women with Primary Breast Cancer. New England Journal of Medicine 350 (11): 1081-92.
12. Cuzick, Jack; Howell, Anthony; and Forbes, John. 2005. Early Stopping of Clinical Trials. Breast Cancer Research 7: 181-83.
13. Dresser, Rebecca. 2002. The Ubiquity and Utility of the Therapeutic Misconception. Social Philosophy and Policy 19: 271-94.
14. Emanuel, Ezekiel J.; Wendler, David; and Grady, Christine. 2000. What Makes Clinical Research Ethical? JAMA 283 (20): 2701-11.
15. Faden, Ruth R., and Beauchamp, Tom L. 1986. A History and Theory of Informed Consent. New York: Oxford University Press.
16. Freedman, Benjamin. 1987. Equipoise and the Ethics of Clinical Research. New England Journal Medicine 317 (3): 141-45.
17. Fried, Charles. 1974. Medical Experimentation: Personal Integrity and Social Policy. Amsterdam: North-Holland Publishing Company.
18. Friedlin, Boris, and Korn, Edward L. 2009. Stopping Clinical Trials Early for Benefit: Impact on Estimation. Clinical Trials 6: 119-25.
19. Gifford, Fred. 1995. Community Equipoise and the Ethics of Randomized Clinical Trials. Bioethics 9: 127-48.
20. Gifford, Fred. 2000. Freedman's "Clinical Equipoise" and "Sliding Scale All-Dimensions-Considered Equipoise". Journal of Medicine and Philosophy 25: 399-426.
21. Goodman, Steven N. 2007. Stopping at Nothing? Some Dilemmas of Data Monitoring in Clinical Trials. Annals of Internal Medicine 146 (12): 882-87.
22. Goss, Paul E.; Ingle, James; Martino, Silvana; et al. 2003. A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer. New England Journal of Medicine 349 (19): 1793-1802.
23. Grinell, Frederick. 1990. Endings of Research Protocols: Distinguishing Therapy from Research. IRB: Ethics and Human Research 12 (4): 1-3.
24. Hansson, Sven Ove. 2004. Weighing Risks and Benefits. Topoi 23: 145-52.
25. Hansson, Sven Ove. 2006. Uncertainty and the Ethics of Clinical Trials. Theoretical Medicine and Bioethics 27: 149-67.
26. Iltis, Ana S. 2005. Stopping Trials Early for Commercial Reasons: The Risk-Benefit Relationship as a Moral Compass. Journal of Medical Ethics 31: 410-14.
27. Jansen, Lynn A. 2009. Altruism in Clinical Research. Hastings Center Report 39 (4): 26-36.
28. Joffe, Steven, and Miller, Frank G. 2008. Bench to Bedside: Mapping the Moral Terrain of Clinical Research. Hastings Center Report 38 (2): 30-42.
29. Lièvre, Michel; Ménard, Jöel; Bruckert, Eric; et al. 2001. Premature Discontinuation of Clinical Trials for Reasons Not Related to Efficacy, Safety, or Feasibility. British Medical Journal 322: 603-5.
30. Marquis, Don. 1983. Leaving Therapy to Chance. Hastings Center Report 13 (4): 40-47.
31. Meier, Paul. 1979. Terminating a Trial-The Ethical Problem. Clinical Pharmacology and Therapeutics 25: 633-40.
32. Miller, Franklin G., and Brody, Howard. 2002. What Makes Placebo-Controlled Trials Unethical? American Journal of Bioethics 2 (2): 3-9.
33. Miller, Franklin G., and Brody, Howard. 2003. A Critique of Clinical Equipoise: Therapeutic Misconception in the Ethics of Clinical Trials. Hastings Center Report 33 (3): 19-28.
34. Miller, Franklin G., and Brody, Howard. 2007. Clinical Equipoise and the Incoherence of Research Ethics. Journal of Medicine and Philosophy 32: 151-65.
35. Miller, Franklin G., and Wendler, David. 2008. Is It Ethical to Keep Interim Findings of Randomised Controlled Trials Confidential? Journal of Medical Ethics 34: 198-201.
36. Miller, Paul B., and Weijer, Charles. 2003. Rehabilitating Equipoise. Kennedy Institute of Ethics Journal 13: 93-118.
37. Montori, Victor M.; Devereaux, P. J.; Adhikari, Niell, K. J.; et al. 2005. Randomized Trials Stopped Early for Benefit: A Systematic Review. JAMA 294 (17): 2203-9.
38. Mueller, Paul S.; Montori, Victor M.; Bassler, Dirk; et al. 2007. Ethical Issues in Stopping Randomized Trials Early Because of Apparent Benefit. Annals of Internal Medicine 146 (12): 878-81.
39. Piccart-Gebhart, Martine J. 2004. New Stars in the Sky of Treatment for Early Breast Cancer. New England Journal of Medicine 350 (11): 1140-42.
40. Pocock, Stuart J. 1992. When to Stop a Clinical Trial. British Medical Journal 350: 235-40.
41. Psaty, Bruce M., and Rennie, Drummond. 2003. Stopping Medical Research to Save Money: A Broken Pact with Researchers and Patients. JAMA 289 (16): 2128-31.
42. Resnik, David B. 2003. Exploitation in Biomedical Research. Theoretical Medicine and Bioethics 24: 233-59.
43. Schafer, Arthur. 1985. The Randomized Controlled Trial: For Whose Benefit? IRB: Ethics and Human Research 7 (2): 4-6.
44. Slutsky, Arthur S., and Lavery, James V. 2004. Data Safety and Monitoring Boards. New England Journal of Medicine 350 (11): 1143-47.
45. Trotta, Francesco; Apolone, Giovanni; Garattini, Silvio; et al. 2008. Stopping a Trial Early in Oncology: For Patients or for Industry? Annals of Oncology 19: 1347-53.
46. Veatch, Robert M. 1979. Longitudinal Studies, Sequential Design, and Grant Renewals: What to Do with Preliminary Data. IRB: Ethics and Human Research 1 (4): 1-3.
47. Veatch, Robert M. 2007. The Irrelevance of Equipoise. Journal of Medicine and Philosophy 32: 167-83.
48. Wells, Robert J.; Gartside, Peter S.; and McHenry, Christine L. 2000. Ethical Issues Arising When Interim Data in Clinical Trials Is Restricted to Independent Data Monitoring Committees. IRB: Ethics and Human Research 22 (1): 7-11.
49. Wertheimer, Alan. 1996. Exploitation. Princeton, NJ: Princeton University Press.
50. Wilkinson, Stephen. 2003. Bodies for Sale: Ethics and Exploitation in the Human Body Trade. London: Routledge.
51. Worrall, John. 2008. Evidence and Ethics in Medicine. Perspectives in Biology and Medicine 51: 418-31.